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Eye surgery, in general, and macular surgery (vitrecto-
my), in particular, have undergone a remarkable techno-
logical evolution. Operations that were barely contem-
plated 10 years ago are now conducted as a matter of
course, and it is hardly conceivable what the next decade
will bring forth in the way of technical advancements.
The international symposium: “Eye surgery/vitrectomy—
past, present and future” was held in late February 2004 in
Bern, Switzerland, with a view to laying bare this dra-
matic evolution from past to the present time—through
the working years of the retiring head of the Department
of Ophthalmology, University of Bern, Prof. F. Koerner—
and to speculating on potentially fruitful directions of
pursuit in the near future.
The main topics discussed in the symposium were:
vitrectomy in children, vitrectomy in cases of inflamma-
tory eye disease, posterior vitreous detachment and its
consequences, vitreolysis and the development of PVR,
the treatment of occlusive vascular and proliferative dis-
eases, and strategies for maintenance and replacement of
retinal function. But other issues that have a high impact
on routine ophthalmologic practice were also addressed.
From the broad range of subjects dealt with, five repre-
sentative papers have been selected for presentation here,
each of which reflects a problem that has figured largely
in the evolution of vitreoretinal microsurgical techniques:
1. “Anomalous posterior vitreous detachment: a unifying
concept in vitreoretinal diseases” by Prof. Dr J. Sebag
(Los Angeles). This review summarizes our current
understanding of the development of vitreoretinal
problems that culminate in retinal detachment.
2. “Strategies to Influence PVR development” by Prof.
Dr B. Kirchhof (Cologne). This article describes in-
terventions that may have an important bearing on the
successful treatment of PVR.
3. “Surgical treatment of diabetic retinopathy” by PD Dr
H. Helbig (Zuerich). This discourse puts recent ad-
vances in the surgical treatment of diabetic retinopathy
into perspective and assesses the current benefits and
limitations of technical developments in vitrectomy
cutters and machines which permit the removal of even
a well-structured vitreous without inevitable damage to
the retina.
4. “Pathopysiological pathways in age-related macular
disease” by Dr F. Roth, Dr A. Bindewald and Prof.
F.G. Holz (Bonn). This paper provides an update of
our current understanding of the problems underlying
age-related macular disease and furnishes guidance on
the clinical management of this condition.
5. “Retinal replacement” by Dr H.G. Sachs and Prof. V.P.
Gabel (Regensburg). This presentation reflects on the
visual quality currently achievable using retinal-re-
placement prostheses and follows the development of
the surgical technique employed for their implantation.
The dramatic evolution in vitreoretinal microsurgical
techniques, as well in the adjunctive medical therapeutic
strategies that contribute to surgical success, would not
have been conceivable without improvements in our un-
derstanding of the pathophysiology of the diseases treat-
ed. The technological developments, which have gone
hand in hand with improvements in our knowledge and
understanding, have now brought us to such a pitch that
visual function can be preserved or restored in cases that
would have been deemed hopeless of treatment not many
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years ago. This situation has been achieved thanks to the
active interest and co-operation of ophthalmologic com-
munities in many European centres and to enduring
governmental and industrial support. Looking to the fu-
ture, I hope that the enthusiasm of ophthalmologists and
ophthalmological societies will lead to a further expan-
sion of the networking system which alone can overcome
the limitations intrinsic to single centres. I also trust that
we can rely on the continued undinted support of gov-
ernmental and industrial bodies. Needless to say, their
financial backing is indispensable for further progress in
this common field of interest to which Prof. Fritz Koerner
has dedicated so many of his active working years.
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